USP5 and hepatocellular carcinoma: We performed survival analysis in HCC patients, and the results showed that a poor prognosis was linked to the high expression of USP5 and LSH (Figure S6C,D), and patients with high expression of both USP5 and LSH showed the worst prognosis (Figure 7E).